Class 3A state sports writers and Morning Call All-Area player of the year Eli Zimmerman announced this week that he is committed to Bloomsburg University. The Northwestern Lehigh senior made it ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

We expect Eli Lilly’s P/E ratio in 2025 to be 60 with an EPS of $19.11, resulting in a price target of $1140.00 This prediction is based on strong revenue growth of 18.37% to $52.80 billion and ...

The FDA ap­proved Eli Lil­ly’s Omvoh in Crohn’s dis­ease, the com­pa­ny an­nounced Wednes­day, hand­ing the drug its sec­ond in­di­ca­tion af­ter giv­ing it a green light … ...

BRIDGEVIEW, Ill. (WGN) — Palestinians from the Chicagoland area gathered in Bridgeview Wednesday following the announcement of a ceasefire in the Gaza Strip. The deal puts a pause on the ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

CHICAGO (WGN) — The Chicago White Sox announced they agreed to terms on contracts with 16 international players Wednesday, which include two players ranked inside Baseball America’s Top 100 ...

Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall Street expectations. The ...

What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...

Lilly plans to share its full Q4 2024 results on 6 February 2025. Credit: JHVEPhoto via Getty Images. Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, marking a 3% shortfall ...

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 ...

Eli Lilly and Co. LLY Eli Lilly’s shares fell 6.59%, closing at $744.91. The stock had an intraday high of $784.23 and a low of $729, with a 52-week range of $612.7 to $972.53. The company ...